NOVAZZI, FEDERICA
 Distribuzione geografica
Continente #
NA - Nord America 3.393
EU - Europa 2.119
AS - Asia 1.805
SA - Sud America 228
AF - Africa 51
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 2
Totale 7.604
Nazione #
US - Stati Uniti d'America 3.309
IT - Italia 1.293
SG - Singapore 753
CN - Cina 391
HK - Hong Kong 248
VN - Vietnam 193
BR - Brasile 185
DE - Germania 125
GB - Regno Unito 119
FR - Francia 114
SE - Svezia 109
IE - Irlanda 108
IN - India 71
RU - Federazione Russa 65
FI - Finlandia 63
BD - Bangladesh 57
MX - Messico 38
CA - Canada 33
ES - Italia 26
PL - Polonia 22
AT - Austria 20
AR - Argentina 19
JP - Giappone 19
NL - Olanda 19
IQ - Iraq 16
ZA - Sudafrica 16
TR - Turchia 13
NG - Nigeria 11
LT - Lituania 10
BE - Belgio 8
CL - Cile 8
KE - Kenya 8
ID - Indonesia 7
PK - Pakistan 6
UA - Ucraina 6
AU - Australia 5
MA - Marocco 5
EC - Ecuador 4
PE - Perù 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
DZ - Algeria 3
JM - Giamaica 3
MY - Malesia 3
PH - Filippine 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
VE - Venezuela 3
CH - Svizzera 2
CO - Colombia 2
DO - Repubblica Dominicana 2
GE - Georgia 2
GT - Guatemala 2
IL - Israele 2
IR - Iran 2
KZ - Kazakistan 2
LB - Libano 2
PT - Portogallo 2
PY - Paraguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BG - Bulgaria 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DK - Danimarca 1
ET - Etiopia 1
EU - Europa 1
GA - Gabon 1
GD - Grenada 1
IM - Isola di Man 1
JO - Giordania 1
LY - Libia 1
MD - Moldavia 1
MO - Macao, regione amministrativa speciale della Cina 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
RO - Romania 1
SA - Arabia Saudita 1
TG - Togo 1
TJ - Tagikistan 1
UY - Uruguay 1
Totale 7.604
Città #
Milan 798
San Jose 476
Singapore 440
Ashburn 331
Dallas 305
Hong Kong 248
Chicago 146
Chandler 129
Los Angeles 119
Fairfield 113
Council Bluffs 107
Beijing 106
Dublin 102
The Dalles 93
Rome 92
Nyköping 83
Princeton 82
New York 80
Lauterbourg 70
Boardman 69
Ho Chi Minh City 63
Salt Lake City 56
London 52
Helsinki 40
Hanoi 39
Buffalo 36
Cambridge 36
Santa Clara 35
Tampa 35
Houston 34
Munich 32
San Diego 32
Frankfurt am Main 31
Chennai 30
Lancaster 27
Elk Grove Village 26
Seattle 26
Orem 25
São Paulo 25
Washington 23
Wilmington 23
Woodbridge 23
Mexico City 22
Nuremberg 21
Varese 19
Ogden 18
Warsaw 18
Tokyo 17
Como 16
Denver 15
Brooklyn 14
Johannesburg 12
Laxou 12
Turku 12
Abuja 11
Boston 11
Poplar 11
San Francisco 11
Sterling 11
Vienna 11
Amsterdam 10
Ann Arbor 10
Falkenstein 10
Guangzhou 10
Manchester 10
Montreal 10
Stockholm 10
Cologno Monzese 9
Da Nang 9
Düsseldorf 9
Mumbai 9
Phoenix 9
Shanghai 9
Shenzhen 9
Atlanta 8
Genoa 8
Málaga 8
Ankara 7
Baghdad 7
Catania 7
Cavaria con Premezzo 7
Detroit 7
Dhaka 7
Kilburn 7
Lappeenranta 7
Malga Leno 7
Paris 7
Rio de Janeiro 7
Toronto 7
Bologna 6
Brussels 6
Dulles 6
Haiphong 6
Hangzhou 6
Hải Dương 6
Mombasa 6
Ottawa 6
Querétaro 6
Verona 6
Brasília 5
Totale 5.306
Nome #
Characterization of a lineage C.36 SARS-CoV-2 isolate with reduced susceptibility to neutralization circulating in Lombardy, Italy 479
Introduction of SARS-CoV-2 variant of concern 20h/501Y.V2 (B.1.351) from Malawi to Italy 224
Multicenter Cross-sectional Study on the Epidemiology of Human Metapneumovirus in Italy, 2022–2024, With a Focus on Adults Over 50 Years of Age 163
An Italian Multicenter Study on the Epidemiology of Respiratory Syncytial Virus During SARS-CoV-2 Pandemic in Hospitalized Children 161
Circulating SARS-CoV-2 variants in Italy, October 2020-March 2021 159
Emergence of SARS-COV-2 Spike Protein Escape Mutation Q493R after Treatment for COVID-19 149
Comparative analysis of SARS-CoV-2 quasispecies in the upper and lower respiratory tract shows an ongoing evolution in the spike cleavage site. 138
Impact of SARS-CoV-2 Omicron and Delta variants in patients requiring intensive care unit (ICU) admission for COVID-19, Northern Italy, December 2021 to January 2022 136
SARS-CoV-2 detection in primary thyroid sarcoma: coincidence or interaction? 136
Detection of the SARS-CoV-2 in different biologic specimens from positive patients with COVID-19, in Northern Italy 133
Clinical characteristics of coronavirus disease (COVID-19) early findings from a teaching hospital in Pavia, North Italy, 21 to 28 February 2020 132
Breakthrough Infections of E484K-Harboring SARS-CoV-2 Delta Variant, Lombardy, Italy 131
12 weeks ombitasvir/paritaprevir–ritonavir + ribavirin achieve high SVR rates in HCV-4 patients with advanced fibrosis 131
Introduction of SARS-COV-2 C.37 (WHO VOI lambda) from Peru to Italy 128
EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count 128
Asymptomatic SARS-CoV-2 vaccine breakthrough infections in health care workers identified through routine universal surveillance testing 123
Baseline amino acid substitutions in the NS5A ISDR and PKR binding domain of hepatitis C and different fibrosis levels and levels of development of hepatocellular carcinoma in patients treated with DAAs 121
Detection of Torquetenovirus and Redondovirus DNA in Saliva Samples from SARS-CoV-2-Positive and -Negative Subjects 117
TTV and other anelloviruses: The astonishingly wide spread of a viral infection 113
Lack of SARS-CoV-2 RNA environmental contamination in a tertiary referral hospital for infectious diseases in Northern Italy 113
Genomic surveillance of SARS-CoV-2 positive passengers on flights from China to Italy, December 2022 111
Emergence of Letermovir-resistant HCMV UL56 mutant during rescue treatment in a liver transplant recipient with ganciclovir-resistant infection HCMV: a case report 111
Imported SARS-COV-2 Variant P.1 Detected in Traveler Returning from Brazil to Italy 109
SARS-CoV-2 B.1.1.7 reinfection after previous COVID-19 in two immunocompetent Italian patients 109
Humoral and cell-mediated response against SARS-CoV-2 variants elicited by mRNA vaccine BNT162b2 in healthcare workers: a longitudinal observational study 108
Expansion of L452R-Positive SARS-CoV-2 Omicron Variant, Northern Lombardy, Italy 107
Symptomatic SARS-CoV-2 infections after full schedule BNT162b2 vaccination in seropositive healthcare workers: a case series from a single institution 105
Emergency Department and Out-of-Hospital Emergency System (112—AREU 118) integrated response to Coronavirus Disease 2019 in a Northern Italy centre 102
Viral dynamics among HCV infected patients with different genotypes treated with genotypic specific or pan-genotypic direct-acting antiviral agent combinations 101
Occurrence of extended spectrum β-lactamases, KPC-Type, and MCR-1.2-producing enterobacteriaceae from wells, river water, and wastewater treatment plants in Oltrepò Pavese area, Northern Italy 101
Genomic epidemiology of SARS-CoV-2 reveals multiple lineages and early spread of SARS-CoV-2 infections in Lombardy, Italy 100
SARS Cov-2 infection in a renal-transplanted patient: A case report 97
Tocilizumab for treatment of severe covid-19 patients: Preliminary results from smatteo covid19 registry (smacore) 96
Severe acute respiratory syndrome coronavirus 2 RNA contamination of inanimate surfaces and virus viability in a health care emergency unit 95
Performance Assessment of the LIAISON® SARS-CoV-2 Antigen Assay On Nasopharyngeal Swabs 93
Genomic Epidemiology of the Main SARS-CoV-2 Variants Circulating in Italy During the Omicron Era 91
On the lookout for influenza viruses in Italy during the 2021-2022 season: along came A(H3N2) viruses with a new phylogenetic makeup of their hemagglutinin 91
Spread of multiple SARS-CoV-2 lineages April-August 2020 anticipated the second pandemic wave in Lombardy (Italy) 89
Human Herpes Virus 7-related encephalopathy in children 89
A CLUSTER OF SARS-COV-2 DELTA VARIANT OF CONCERN ADDITIONALLY HARBORING F490S, NORTHERN LOMBARDY, ITALY 88
Combined Use of Phenotypic Screening and of a Novel Commercial Assay (REALQUALITY Carba-Screen) for the Rapid Molecular Detection of Carbapenemases: A Single-Center Experience 86
Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy 86
Sotrovimab-emergent resistance in SARS-CoV-2 Omicron: A series of three cases 86
Multicenter prospective study on the prevalence of colistin resistance in escherichia coli: Relevance of mcr-1-positive clinical isolates in Lombardy, Northern Italy 84
Rapid response to COVID-19 outbreak in Northern Italy: how to convert a classic infectious disease ward into a COVID-19 response centre 84
SARS-CoV-2 positivity in rectal swabs: implication for possible transmission 83
Sars-cov-2 virologic and immunologic correlates in patients with olfactory and taste disorders 83
Epidemiological impact of human adenovirus as causative agent of respiratory infections: An Italian multicentre retrospective study, 2022–2023 82
Rapid and sensitive detection of SARS-CoV-2 RNA using the Simplexa™ COVID-19 direct assay 82
Comparison of Different HIV-1 Resistance Interpretation Tools for Next-Generation Sequencing in Italy 81
JN.1 variants circulating in Italy from October 2023 to April 2024: genetic diversity and immune recognition 81
Effect of Cigarette Smoking on Clinical and Molecular Endpoints in COPD Patients 81
Multicenter epidemiological investigation and genetic characterization of respiratory syncytial virus and metapneumovirus infections in the pre-pandemic 2018-2019 season in northern and central Italy 81
Epidemiological characteristics of non-polio enteroviruses in respiratory infections: An Italian multicentre retrospective study, 2022–2023 79
Molecular characterization of emerging Echovirus 11 (E11) shed light on the recombinant origin of a variant associated with severe hepatitis in neonates 76
Molecular characterization of influenza strains in patients admitted to intensive care units during the 2017-2018 season 76
Torquetenovirus Viremia Quantification Using Real-Time PCR Developed on a Fully Automated, Random-Access Platform 70
Spike protein evolution in the SARS-CoV-2 Delta variant of concern: a case series from Northern Lombardy 70
How multiplex testing approach to respiratory viruses detection can enhance influenza surveillance 70
A family cluster of Streptococcus pyogenes associated with a fatal early-onset neonatal sepsis 69
Performance of VivaDiag COVID-19 IgM/IgG Rapid Test is inadequate for diagnosis of COVID-19 in acute patients referring to emergency room department 69
Viral dynamics among HCV infected patients with different genotypes treated with genotypic specific or pan-genotypic direct-acting antiviral agent combinations 68
Safety and immunogenicity of synchronous COVID19 and influenza vaccination 67
TTV Species Diversity as a Novel Biomarker of Immune Dysregulation in Aging 62
TTV viral load as a predictor of antibody response to SARS COV-2 vaccination 61
Plasma Torquetenovirus (TTV) microRNAs and severity of COVID-19 61
Association Between TTV Viremia, Chronic Inflammation, and Ischemic Heart Disease Risk: Insights From MARK-AGE and Report-Age Projects 60
A new case of Echovirus 11 neonatal fulminant hepatitis involving male twins in a Northern Italy Tertiary University Hospital: Insight on a possible immunological clue 59
Post-pandemic upsurge in Group A Streptococcus infections at an Italian tertiary university hospital 59
Ongoing post-pandemic peak of Mycoplasma pneumoniae cases in July 2024: A single-center experience in north-west Italy 54
Monkeypox: An international epidemic 53
Enhanced laboratory surveillance of respiratory infection disclosed the rapid rise of enterovirus D68 cases, northern Italy, August to September 2024 51
Expression Patterns of Interferons and Proinflammatory Cytokines in the Upper Respiratory Tract of Patients Infected by Different Viral Pathogens: Correlation with Age and Viral Load 42
Rise of the BQ.1.1.37 SARS-CoV-2 Sublineage, Italy 39
SARS-CoV-2 recombinant XN, Italy 37
Global spread of Streptococcus pyogenes A genomics-supported narrative review 34
Two dramatically different clinical scenarios of neonatal Echovirus-11 infection in late preterm male twins: a case report and review of the literature 34
Genetic variability of respiratory syncytial virus and its impact on monoclonal antibody binding sites: a national cross-sectional study during the 2023–2024 season 29
The effect of torque teno virus (TTV) infection on clinical outcomes, genomic integrity, and mortality in COPD patients 27
Investigating the evolutionary dynamics and mutational pattern of SARS-CoV-2 spike gene on selected SARS-CoV-2 variants 26
Networking of public health and clinical laboratories: a successful strategy to uncover promptly two enterovirus D68 outbreaks in Lombardy region (northern Italy), July 2021-November 2022 23
Torque Teno Virus Levels During Viral Respiratory Infections: The Interplay With Immune Dysregulation and Coagulopathy Biomarkers 23
RSV epidemiology in Italian adults over 60: a multicenter cross-sectional study 22
Maggot-associated Ignatzschineria larvae bacteremia: a case report. 21
Large norovirus GII.17 outbreak in a school in Northern Italy: A novel emerging sublineage within an emerging genotype? 19
Methylation patterns associated with TTV load in geriatric hospitalized patients: an exploratory functional analysis 9
Expression Patterns of Interferons and Proinflammatory Cytokines in the Upper Respiratory Tract of Patients Infected by Different Viral Pathogens: Correlation with Age and Viral Load 6
The gut and circulating virome: emerging players in aging and longevity 6
High Torque teno virus viremia predicts long-term mortality and reflects chronic low-grade inflammation (inflammaging) in geriatric inpatients 5
Clinical Sampling Challenges in Diagnosing Severe Respiratory Viral Infections 3
Metabolic determinants of torque teno virus load across the diabetes spectrum: insights from a cross-sectional analysis 3
Cytokine and Endothelial Activation Patterns Related to Severe and Non-Severe Respiratory Viral Infections 3
Totale 7.833
Categoria #
all - tutte 42.111
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.111


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202155 0 0 0 0 0 0 0 0 0 0 0 55
2021/2022536 20 30 31 29 13 40 42 94 29 91 34 83
2022/2023585 55 43 53 33 26 111 17 87 101 24 15 20
2023/20241.349 185 205 185 247 264 128 18 17 37 23 26 14
2024/20251.647 8 16 182 70 36 66 53 86 139 255 331 405
2025/20263.625 226 164 345 521 360 125 717 280 328 254 207 98
Totale 7.833